BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7382624)

  • 21. IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.
    Hall RP; Lawley TJ; Heck JA; Katz SI
    Clin Exp Immunol; 1980 Jun; 40(3):431-7. PubMed ID: 7418261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment and prognosis of rapidly progressive glomerulonephritis.
    Keller F; Oehlenberg B; Kunzendorf U; Schwarz A; Offermann G
    Clin Nephrol; 1989 Apr; 31(4):190-7. PubMed ID: 2714023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monthly plasmapheresis for systemic lupus erythematosus with diffuse proliferative glomerulonephritis: a pilot study.
    Clark WF; Lindsay RM; Cattran DC; Chodirker WB; Barnes CC; Linton AL
    Can Med Assoc J; 1981 Jul; 125(2):171-4. PubMed ID: 7272867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic kidney disease.
    Bock GH; Vernier RL
    Am Fam Physician; 1980 Nov; 22(5):87-96. PubMed ID: 6448541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
    De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
    Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmapheresis combined with corticosteroids and cyclophosphamide in uncontrolled active systemic lupus erythematosus.
    Schildermans F; Dequeker J; Van de Putte I
    J Rheumatol; 1979; 6(6):687-90. PubMed ID: 529252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of prednisone in the development of nephropathy in Schoenlein-Henoch purpura].
    Buchanec J; Galanda V; Beláková S; Minárik M; Zibolen M
    Cesk Pediatr; 1989 Mar; 44(3):145-6. PubMed ID: 2731281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and the clinical application. h. Glomerulonephritis].
    Sato M; Tamura K; Koshikawa S
    Nihon Rinsho; 1984 Aug; 42(8):1893-9. PubMed ID: 6392611
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasmapheresis in hereditary angioneurotic edema and systemic lupus erythematosus.
    Young DW; Thompson RA; Mackie PH
    Arch Intern Med; 1980 Jan; 140(1):127-8. PubMed ID: 7352788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case of Schönlein-Hennoch disease with severe endo- and extracapillary glomerulonephritis].
    Teodosiev L; Konstantinova V; Vasilev I
    Vutr Boles; 1978; 17(1):90-4. PubMed ID: 654227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyclophosphamide stosstherapy synchronized with plasmapheresis in rapidly progressive glomerulonephritis].
    Gutschmidt HJ; Euler HH; Albrecht J; Asbeck F; Kleine LH; von Klinggräff C; Löffler H
    Dtsch Med Wochenschr; 1986 Sep; 111(38):1439-44. PubMed ID: 3757801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of azathioprine on renal histology and function in lupus nephritis.
    Shelp WD; Bloodworth JM; Rieselbach RE
    Arch Intern Med; 1971 Oct; 128(4):566-73. PubMed ID: 5111661
    [No Abstract]   [Full Text] [Related]  

  • 34. [Initial plasmapheresis treatment results in glomerulonephritis].
    Nenov D; Stanchev I; Chankova P
    Vutr Boles; 1981; 20(2):105-8. PubMed ID: 7257329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lupus nephropathy. Treatment with the indomethacin-hydroxychloroquine combination and comparison with corticoids].
    Conte JJ; Mignon-Conte MA; Fournie GJ
    Nouv Presse Med; 1975 Jan; 04(2):91-5. PubMed ID: 1138230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases.
    Naarendorp M; Kerr LD; Khan AS; Ornstein MH
    J Rheumatol; 1999 Oct; 26(10):2257-60. PubMed ID: 10529151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of severe systemic lupus erythematosus. Long-term results in 55 patients (author's transl)].
    Jungers P; Dougados M; Tron F; Lesavre P; Leibowitch J; Noël LH; Bach JF
    Nouv Presse Med; 1980 Sep; 9(33):2329-37. PubMed ID: 7433023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Severe Schonlein-Henoch nephritis in adults. A report of twenty cases].
    Schillinger F; Denis PS; Dion JJ; Montagnac R; Melin JP; Milcent T; Beghoura R; Birembaut P; Chanard J
    Nephrologie; 2000; 21(5):247-52. PubMed ID: 11068774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.